Content area

|
|

Primært centralnervesystemlymfom

Forfatter(e)

Rune Sommer-Sørensen1, Karen Juul-Jensen2, Thomas Stauffer Larsen2, Michael Boe Møller3, Bo Halle1, Mette Kathrine Schulz1, Christian Bonde Pedersen1 & Frantz Rom Poulsen1

1) Neurokirurgisk Afdeling, Odense Universitetshospital, 2) Hæmatologisk Afdeling, Odense Universitetshospital, 3) Afdeling for Klinisk Patologi, Odense Universitetshospital

Ugeskr Læger 2020;182:V01200065

Reference: 
UgeskrLæger2020;182:V01200065
Blad nummer: 
Primary central nervous system lymphomas

Rune Sommer-Sørensen, Karen Juul-Jensen, Thomas Stauffer Larsen, Michael Boe Møller, Bo Halle, Mette Kathrine Schulz, Christian Bonde Pedersen & Frantz Rom Poulsen

Ugeskr Læger 2019;181:V01200065

In this review, we discuss primary central nervous system lymphomas: a rare type of tumours confined to the central nervous system. The disease is associated with a poor prognosis, which, however, generally has seen steady improvement over the last four decades, particularly in the younger population. Modern surgical techniques are reserved for diagnosis and has no place in the treatment, which mainly relies on high-dose polychemotherapy treatment regimes with methotrexate as the backbone.

Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Torben Mahneke | 22/10
1 Kommentar
af Flemming Amter | 19/10
1 Kommentar
af Henrik Dibbern | 18/10
1 Kommentar
af Jens Langhoff-Roos | 17/10
3 kommentarer
af Tomas Christensen Kjær | 16/10
1 Kommentar
af Lars Lindberg Andersen | 15/10
1 Kommentar
af Johan Tommy Robert Wallentin | 14/10
1 Kommentar